Archive - NEXT VENTŪRES Newsletter

VO₂ Max Needs a Rebrand

A clinical biomarker masquerading as a performance metric.

Jun 26 •

and

Jordan Pascasio

April 2025

Investing in Cofertility: A Category Creator Within Family Planning

Building families, pioneering change.

Apr 11 •

January 2025

Investing in Eternal: A Targeted Approach Toward Longevity

Health care for athletes, from athletes.

Jan 14 •

October 2024

Elevating Health & Longevity

Drawing on our very own Lance Armstrong, alongside Peter Attia, to break down the latest innovations in human performance and longevity.

Oct 31, 2024 •

November 2023

Investing in Humane: A Step Change in Human-Computer Interaction

Shifting the way we interact with the world around us.

Nov 17, 2023 •

October 2023

Our 20th Investment: Pair Team

Enabling better health outcomes for our most vulnerable communities.

Oct 19, 2023 •

Congressional Briefing Addressing the Gender Health Gap

Next Ventures joins Momentous and the Center for a New American Security to host a panel of world-leading experts on women’s health and performance.

Oct 5, 2023 •

July 2023

Investing in Vital Bio: A New Frontier in Diagnostics

Reimagining lab testing to enable radically accessible care.

Jul 25, 2023 •

VBC Enablement: Paving The Way for Value

Examining the continued rise of VBC enablement and its ability to help transition providers to value.

Jul 24, 2023 •

and

Jordan Pascasio

April 2023

A New Year of Whole-person Health

Reflecting on the market and our thesis, while anticipating thematic developments in the year to come.

Apr 4, 2023 •

December 2022

Our 17th Investment: Juno Medical

The modern doctor's office designed for the 99%.

Dec 14, 2022 •

October 2022

Our 16th Investment: Genopets

Democratizing active lifestyles through immersive gameplay.

Oct 13, 2022 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts